ATE429826T1 - Zusammensetzung zur prävention und/oder behandlung von verändertem knochenmetabolismus - Google Patents
Zusammensetzung zur prävention und/oder behandlung von verändertem knochenmetabolismusInfo
- Publication number
- ATE429826T1 ATE429826T1 AT02707337T AT02707337T ATE429826T1 AT E429826 T1 ATE429826 T1 AT E429826T1 AT 02707337 T AT02707337 T AT 02707337T AT 02707337 T AT02707337 T AT 02707337T AT E429826 T1 ATE429826 T1 AT E429826T1
- Authority
- AT
- Austria
- Prior art keywords
- prevention
- bone metabolism
- treatment
- composition
- altered bone
- Prior art date
Links
- 230000004097 bone metabolism Effects 0.000 title abstract 3
- 230000002265 prevention Effects 0.000 title abstract 2
- 208000000103 Anorexia Nervosa Diseases 0.000 abstract 1
- 208000010392 Bone Fractures Diseases 0.000 abstract 1
- 208000029725 Metabolic bone disease Diseases 0.000 abstract 1
- 206010027476 Metastases Diseases 0.000 abstract 1
- YXOLAZRVSSWPPT-UHFFFAOYSA-N Morin Chemical compound OC1=CC(O)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1 YXOLAZRVSSWPPT-UHFFFAOYSA-N 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 208000010191 Osteitis Deformans Diseases 0.000 abstract 1
- 206010049088 Osteopenia Diseases 0.000 abstract 1
- 208000001132 Osteoporosis Diseases 0.000 abstract 1
- 208000027868 Paget disease Diseases 0.000 abstract 1
- 208000001647 Renal Insufficiency Diseases 0.000 abstract 1
- XADJWCRESPGUTB-UHFFFAOYSA-N apigenin Natural products C1=CC(O)=CC=C1C1=CC(=O)C2=CC(O)=C(O)C=C2O1 XADJWCRESPGUTB-UHFFFAOYSA-N 0.000 abstract 1
- 235000008714 apigenin Nutrition 0.000 abstract 1
- KZNIFHPLKGYRTM-UHFFFAOYSA-N apigenin Chemical compound C1=CC(O)=CC=C1C1=CC(=O)C2=C(O)C=C(O)C=C2O1 KZNIFHPLKGYRTM-UHFFFAOYSA-N 0.000 abstract 1
- 229940117893 apigenin Drugs 0.000 abstract 1
- 210000000988 bone and bone Anatomy 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 238000001631 haemodialysis Methods 0.000 abstract 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 abstract 1
- 201000006370 kidney failure Diseases 0.000 abstract 1
- 208000019423 liver disease Diseases 0.000 abstract 1
- LRDGATPGVJTWLJ-UHFFFAOYSA-N luteolin Natural products OC1=CC(O)=CC(C=2OC3=CC(O)=CC(O)=C3C(=O)C=2)=C1 LRDGATPGVJTWLJ-UHFFFAOYSA-N 0.000 abstract 1
- 235000009498 luteolin Nutrition 0.000 abstract 1
- IQPNAANSBPBGFQ-UHFFFAOYSA-N luteolin Chemical compound C=1C(O)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(O)C(O)=C1 IQPNAANSBPBGFQ-UHFFFAOYSA-N 0.000 abstract 1
- 208000027202 mammary Paget disease Diseases 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 230000009401 metastasis Effects 0.000 abstract 1
- UXOUKMQIEVGVLY-UHFFFAOYSA-N morin Natural products OC1=CC(O)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UXOUKMQIEVGVLY-UHFFFAOYSA-N 0.000 abstract 1
- 235000007708 morin Nutrition 0.000 abstract 1
- 208000015380 nutritional deficiency disease Diseases 0.000 abstract 1
- 230000000010 osteolytic effect Effects 0.000 abstract 1
- 230000035935 pregnancy Effects 0.000 abstract 1
- 238000001356 surgical procedure Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
- A23L33/155—Vitamins A or D
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/29—Berberidaceae (Barberry family), e.g. barberry, cohosh or mayapple
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP01201101 | 2001-03-23 | ||
| PCT/NL2002/000186 WO2002076241A1 (en) | 2001-03-23 | 2002-03-22 | Preparation for the prevention and/or treatment of altered bone metabolism |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE429826T1 true ATE429826T1 (de) | 2009-05-15 |
Family
ID=8180061
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02707337T ATE429826T1 (de) | 2001-03-23 | 2002-03-22 | Zusammensetzung zur prävention und/oder behandlung von verändertem knochenmetabolismus |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20040152640A1 (de) |
| EP (1) | EP1379146B1 (de) |
| AT (1) | ATE429826T1 (de) |
| DE (1) | DE60232140D1 (de) |
| DK (1) | DK1379146T3 (de) |
| ES (1) | ES2325652T3 (de) |
| PT (1) | PT1379146E (de) |
| WO (1) | WO2002076241A1 (de) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1487434B1 (de) * | 2002-03-06 | 2007-05-09 | The Medical Research and Education Trust | Botanischer extrakt mit antikrebs-aktivität enthaltend isoliquiritigenin |
| KR100437274B1 (ko) * | 2003-10-15 | 2004-06-24 | 주식회사 케이엠에스아이 | 연골재생제로서 아피제닌을 함유하는 골관절염 치료 조성물 |
| WO2005085223A1 (ja) * | 2004-03-04 | 2005-09-15 | Erina Co. Inc. | 骨疾患の予防及び/又は治療用組成物、その組成物を含有する機能性食品もしくは健康食品、並びにその組成物を有効成分とする医薬製剤 |
| US20050238739A1 (en) * | 2004-04-23 | 2005-10-27 | Thomas Nisslein | Composition comprising a combination of calcium, cimicifugae racemosae rhizoma and vitamin D and its use as a pharmaceutical in conditions or disorders associated with or resulting from calcium deficiency or as a nutritional supplement |
| WO2010062681A2 (en) * | 2008-10-30 | 2010-06-03 | University Of South Florida | Luteolin and diosmin/diosmetin as novel stat3 inhibitors for treating autism |
| KR101077915B1 (ko) | 2010-04-26 | 2011-10-31 | 한국원자력연구원 | 센티페드그라스 추출물을 유효성분으로 함유하는 암 예방 또는 치료용 약학적 조성물 |
| US9387219B2 (en) | 2011-06-06 | 2016-07-12 | Conopco, Inc. | Edible composition |
| TWI677345B (zh) * | 2018-08-21 | 2019-11-21 | 大江生醫股份有限公司 | 波羅蜜白芯的萃取物用於調控ｃｆｏｓ基因、ｃｓｆ１ｒ基因、ｒａｎｋ基因、ｓｙｋ基因、ｔｒａｐ基因、ａｐａ１基因、ａｂｃａ１基因、ｉｌ-６基因、ｖｃａｍ１基因、ｃａｓｐ８基因、ｄｄｃ基因、及ａｓｍｔｌ蛋白基因的表現量，及改善停經症候群的用途 |
| CN110151753A (zh) * | 2019-06-14 | 2019-08-23 | 贵州理工学院 | 桑色素或其水合物在制备抗骨质疏松药物中的应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH05505935A (ja) * | 1990-02-05 | 1993-09-02 | ボード オブ リージェンツ，ザ ユニバーシティ オブ テキサス システム | ビタミン，ミネラルおよび他の有利な補給剤の徐放性処方 |
| US6444221B1 (en) * | 1992-06-30 | 2002-09-03 | Howard K. Shapiro | Methods of treating chronic inflammatory diseases using carbonyl trapping agents |
| GB9317071D0 (en) * | 1993-08-17 | 1993-09-29 | Univ Strathclyde | Flavonoids |
| GB9600604D0 (en) * | 1996-01-12 | 1996-03-13 | Boots Co Plc | Composition |
| EP0807435A3 (de) * | 1996-05-17 | 1999-02-24 | Sertürner Arzneimittel GmbH | Indirekter HMG-CoA-Reduktase-Hemmer |
| WO1998050026A1 (en) * | 1997-05-01 | 1998-11-12 | Novogen Inc | Treatment or prevention of menopausal symptoms and osteoporosis |
| AU6209700A (en) * | 1999-07-13 | 2001-01-30 | Cedars-Sinai Medical Center | Method and compositions for inhibiting biosynthesis or bioactivity of endogenoussteroid sex hormones in humans |
| US6495170B1 (en) * | 2000-08-16 | 2002-12-17 | N. V. Nutricia | Method of increasing the presence of glutathione in cells |
-
2002
- 2002-03-22 ES ES02707337T patent/ES2325652T3/es not_active Expired - Lifetime
- 2002-03-22 DE DE60232140T patent/DE60232140D1/de not_active Expired - Lifetime
- 2002-03-22 WO PCT/NL2002/000186 patent/WO2002076241A1/en not_active Ceased
- 2002-03-22 AT AT02707337T patent/ATE429826T1/de not_active IP Right Cessation
- 2002-03-22 PT PT02707337T patent/PT1379146E/pt unknown
- 2002-03-22 EP EP02707337A patent/EP1379146B1/de not_active Expired - Lifetime
- 2002-03-22 DK DK02707337T patent/DK1379146T3/da active
- 2002-03-22 US US10/472,438 patent/US20040152640A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2002076241A1 (en) | 2002-10-03 |
| US20040152640A1 (en) | 2004-08-05 |
| EP1379146A1 (de) | 2004-01-14 |
| ES2325652T3 (es) | 2009-09-11 |
| DE60232140D1 (de) | 2009-06-10 |
| PT1379146E (pt) | 2009-09-02 |
| EP1379146B1 (de) | 2009-04-29 |
| DK1379146T3 (da) | 2009-08-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TR199800767T2 (xx) | Proteaz engelleyicileri. | |
| MEP42808A (en) | Use of flibanserin in the treatment of sexual disorders | |
| BRPI0519195A2 (pt) | composiÇço de cuidado oral, e, mÉtodo para prevenir ou tratar cÁrie dental em um indivÍduo humano ou animal | |
| ATE302616T1 (de) | Oral anzuwendende arzneizusammensetzungen mit gesteuerter wirkstoffabgabe | |
| BRPI0414565A (pt) | composições farmacêuticas e métodos que compreendem combinações de derivados de 2-alquilideno-19-nor-vitamina d e um bisfosfonato | |
| DE60120691D1 (de) | Zusammensetzungen zur verwendung bei der behandlung der osteoporose und/oder der entzündlichen gelenkerkrankungen | |
| BR0213540A (pt) | Compostos, método para o tratamento de enfermidades ou distúrbios em um paciente e composição farmacêutica que compreende os mesmos | |
| NO20062355L (no) | Sammensetninger for behandling av sykdom i munnhulen og ovre andedrettssystem | |
| ATE429826T1 (de) | Zusammensetzung zur prävention und/oder behandlung von verändertem knochenmetabolismus | |
| MY144897A (en) | 2,3,4,9-tetrahydro-1h-carbazole derivatives as crth2 receptor antagonists | |
| DE50212760D1 (de) | Ermittlung des patientenbezogenen Kariesrisikos | |
| BR0211932A (pt) | Métodos e composições para administração oral de hormÈnio de paratireóide, pth | |
| DE60115054D1 (de) | Pharmazeutische zusammensetzung die trkaig2 enthält zur verwendung in der vorbeugung und/oder behandlung von krebs | |
| BR9808233A (pt) | Preparação farmacêutica | |
| BR0105787A (pt) | Composição farmacêutica, uso de um composto farmacêutico, método para tratamento de distúrbios, composto farmacêutico e método para confeccionar um composto farmacêutico | |
| CA2431515A1 (en) | Composition comprising bisphosphonates for prevention and/or treatment of metabolic diseases of bones, process for preparing such composition, and use thereof | |
| ATE330616T1 (de) | Verabreichung von bisphosphonaten durch inhalation zur behandlung von knochenresorption und osteoporosis | |
| BR0212249A (pt) | Composto, composição farmacêutica, método de tratamento ou profilaxia de doenças, e, uso de um composto | |
| DK1441723T3 (da) | Anvendelse af irbesartan til fremstilling af lægemidler til forebyggelse eller behandling af pulmonal hypertension | |
| BR0208554A (pt) | Osteoprotegerina no leite | |
| WO2005110413A3 (en) | Medicaments containing n-sulfamoyl-n'-arylpiperazines for the prophylaxis or treatment of obesity and related conditions | |
| HUP0202898A2 (hu) | Integrin receptor antagonisták | |
| PT1231908E (pt) | Composicao farmaceutica compreendendo um composto dador de no e sua utilizacao em terapia | |
| PE20040932A1 (es) | Metodo de mejora de la circulacion sanguinea | |
| MY138502A (en) | Novel alkansulfonamides as endothelin antagonists |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |